Discover the impact of stem cells and regenerative medicine: Canada’s science. Canada’s future.
Canada has been a world leader in regenerative medicine since the 1960s, with the initial experiments conducted by two Canadians — Drs. James Till and Ernest McCulloch — who demonstrated the existence of stem cells. Since
then, Canadian researchers have continued making significant global contributions to areas including muscle stem cells, pancreatic progenitor cells, retinal stem cells, and cancer stem cells.
These discoveries have led to the development of leading-edge therapies for chronic and rare diseases, illness and injury. As a result, Canada has a world-class reputation for research excellence, developing high-quality talent, launching new biotechnology companies, and producing innovations that are changing the face of healthcare.
Discover regenerative medicine impact across Canadian provinces and regions
Explore Canadian biotech companies catalyzed or enhanced through SCN research funding
Explore workforce impact of trainees supported through SCN programs
Read patient stories highlighting regenerative medicine’s life-changing potential
Explore SCN efforts toward improving accessibility and adoption of advanced therapeutics
Invested into regenerative medicine research
Future leaders trained
Leveraged in research partnerships
Clinical trials funded
Biotech companies catalyzed or enhanced
Research projects funded
350 Albert Street,
Suite 325
Ottawa, ON
K1R 1A4
info@stemcellnetwork.ca
Receive the latest news on SCN funding programs and training opportunities, and what’s happening in the stem cell industry, directly in your inbox.
Newsletter sign-up form